Characterizing Notch3 Signaling in Ovarian Cancer
卵巢癌中 Notch3 信号传导的特征
基本信息
- 批准号:8104583
- 负责人:
- 金额:$ 34.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:ABCB1 geneAddressAnimal ModelBindingBiological ProcessCancer BiologyCancer PatientCell NucleusCell ProliferationCell SurvivalClinicalCollaborationsComplexDevelopmentDevelopmental ProcessDiseaseEtiologyFoundationsFutureGene AmplificationGene ExpressionGene TargetingGenesGenetic TranscriptionHumanInjection of therapeutic agentLeadLigandsMalignant NeoplasmsMalignant neoplasm of ovaryMediatingModelingMolecularMulti-Drug ResistanceMusOncogenicOutcomeOvarianOvarian CarcinomaOvarian Serous AdenocarcinomaPathogenesisPathway interactionsPeptide HydrolasesPhenotypePhysiological ProcessesPolymersProteinsProto-OncogenesRB1 geneReportingRoleSignal PathwaySignal TransductionTP53 geneTestingTissuesTransgenic MiceUp-RegulationWomanbasecancer cellcancer therapyembryonic stem cellinhibitor/antagonistmouse modelneoplasticneoplastic cellnotch proteinovarian neoplasmoverexpressionreceptorsecretasesmall moleculetumortumor progressiontumor xenografttumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The main objective of this study is to elucidate the role of Notch3 signaling in the pathogenesis of ovarian cancer, one of the most lethal neoplastic diseases in women. It has been well-established that the Notch signaling is required during diverse developmental and physiological processes and aberration of the signaling pathway participates in cancer development. Based on our recent findings showing Notch3 gene amplification in ovarian cancers and its role in maintaining cell survival, we hypothesize that i) activation of Notch3 signaling pathway initiates tumor formation and/or propel tumor progression; ii) Pbx1, a Notch3-regulated gene, is responsible for the tumor-promoting phenotypes of Notch3 through its interaction with Hox proteins; iii) targeting the Notch3 signaling pathway has anti-tumor potential in cancer cells with active Notch signaling. To test the above hypotheses, we propose the following specific aims: Aim 1: Analyze the roles of Notch3 pathway activation in the development of ovarian carcinoma. Aim 2: Investigate the mechanism by which Pbx1 mediates tumor-promoting effects of Notch3 signaling. Aim 3: Assess anti- tumor potential of pharmacological targeting of the Notch3 pathway. The results from this study will address several critical questions centering the roles of Notch3 in cancer biology and should have implication for future development of Notch3-based target therapy.
PUBLIC HEALTH RELEVANCE: The purpose of this study is to determine the molecular mechanism by which Notch3 pathway activation contributes to the development of ovarian cancer. Furthermore, we will delineate the role of a Notch3 target gene in modulating oncogenic phenotypes in ovarian cancer. We will test tumor suppressive effect using newly developed small molecules to block Notch3-Pbx1 pathway. The results from this study will further our understanding the molecular mechanisms in the tumorigenesis of ovarian cancer and will provide foundation for Notch3-based cancer therapy.
描述(由申请人提供):本研究的主要目的是阐明Notch 3信号传导在卵巢癌发病机制中的作用,卵巢癌是女性中最致命的肿瘤性疾病之一。Notch信号通路在多种发育和生理过程中是必需的,并且信号通路的畸变参与癌症的发展。基于我们最近的研究结果显示Notch 3基因在卵巢癌中的扩增及其在维持细胞存活中的作用,我们假设i)Notch 3信号通路的激活启动肿瘤形成和/或推动肿瘤进展; ii)Pbx 1,一个Notch 3调节基因,通过其与Hox蛋白的相互作用负责Notch 3的肿瘤促进表型; iii)靶向Notch 3信号传导途径在具有活性Notch信号传导的癌细胞中具有抗肿瘤潜力。为了验证上述假设,我们提出了以下具体目标:目的1:分析Notch 3通路激活在卵巢癌发生发展中的作用。目的2:探讨Pbx 1介导Notch 3信号通路促肿瘤作用的机制。目的3:评估Notch 3通路的药理学靶向抗肿瘤潜力。这项研究的结果将解决Notch 3在癌症生物学中作用的几个关键问题,并对未来基于Notch 3的靶向治疗的发展具有意义。
公共卫生关系:本研究的目的是确定Notch 3通路激活有助于卵巢癌发展的分子机制。此外,我们将描述Notch 3靶基因在调节卵巢癌致癌表型中的作用。我们将测试使用新开发的小分子阻断Notch 3-Pbx 1通路的肿瘤抑制效果。本研究的结果将有助于我们进一步了解卵巢癌发生的分子机制,并为基于Notch 3的肿瘤治疗提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tian-Li Wang其他文献
Tian-Li Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tian-Li Wang', 18)}}的其他基金
TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA
靶向脾酪氨酸激酶治疗化疗耐药卵巢癌
- 批准号:
8889234 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA
靶向脾酪氨酸激酶治疗化疗耐药卵巢癌
- 批准号:
8754936 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
Characterizing Notch3 Signaling in Ovarian Cancer
卵巢癌中 Notch3 信号传导的特征
- 批准号:
8627578 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
Characterizing Notch3 Signaling in Ovarian Cancer
卵巢癌中 Notch3 信号传导的特征
- 批准号:
8825442 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
Characterizing Notch3 Signaling in Ovarian Cancer
卵巢癌中 Notch3 信号传导的特征
- 批准号:
8449501 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
Characterizing Notch3 Signaling in Ovarian Cancer
卵巢癌中 Notch3 信号传导的特征
- 批准号:
8233296 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.03万 - 项目类别:
Research Grant